Anti-LIGHT antibody

Rs. 50,211.00
SKU stj93926

General Information

Product name Anti-LIGHT antibody
Short Description
Description Rabbit polyclonal to LIGHT.
Applications IF,ELISA
Dilution range IF 1:200-1:1000ELISA 1:20000
Protein Name Anti-LIGHT antibody
Immunogen Synthesized peptide derived from human LIGHT
Storage Instruction Store at -20°C, and avoid repeat freeze-thaw cycles.
Type of Usage For Research Use Only (RUO).

Product Properties

Host Rabbit
Clonality Polyclonal
Reactivity Human,Mouse
Conjugation Unconjugated
Purification The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Isotype IgG
Formulation Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Target

Gene ID
Gene Symbol
Molecular Weight 26.351 kDa
Database Links
Alternative Names Tumor necrosis factor ligand superfamily member 14 antibody
Herpes virus entry mediator ligand antibody
HVEM-L antibody
Herpesvirus entry mediator ligand antibody
CD antigen CD258 antibody
Tumor necrosis factor ligand superfamily member 14, membrane form antibody
Tumor necrosis factor ligand superfamily member 14, soluble form antibody
HVEML antibody
UNQ391/PRO726 antibody
Function Cytokine that binds to TNFRSF3/LTBR. Binding to the decoy receptor TNFRSF6B modulates its effects. Activates NFKB, stimulates the proliferation of T-cells, and inhibits growth of the adenocarcinoma HT-29. Acts as a receptor for Herpes simplex virus.
Cellular Localization Tumor necrosis factor ligand superfamily member 14, membrane form: Cell membrane. Single-pass type II membrane protein.. Tumor necrosis factor ligand superfamily member 14, soluble form: Secreted.. Isoform 2: Cytoplasm.
Tissue Specificity Predominantly expressed in the spleen but also found in the brain. Weakly expressed in peripheral lymphoid tissues and in heart, placenta, liver, lung, appendix, and kidney, and no expression seen in fetal tissues, endocrine glands, or nonhematopoietic tumor lines.
Swiss-Prot Key

 

You recently viewed

Clear recently viewed
Print Friendly and PDF